Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first rapid-acting insulin ...

A chronic medical condition, diabetes results in the body's inability to produce enough insulin or use it effectively, leading to high blood sugar levels. Interestingly, Novolog Mix 70 or 30 ...

Products like novolog, novomix, and novorapid are contributing significantly to diabetes management by providing rapid-acting insulin for quick blood sugar reduction and, in the case of novomix ...

In the kitchen of her South St. Paul home, Abigail Turner prepares the insulin she uses to manage her type 1 diabetes last February. Minnesota announced a final settlement Monday with the last of ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest ...

“Without insulin, I die.” Novo Nordisk manufactures insulin products like NovoLog, Tresiba, Fiasp and Novolin. Novo Nordisk will also provide free insulin to qualifying patients below a ...

The company will also provide free insulin for Minnesotans who are the most in need. Those products include Novolog, Tresiba, Fiasp, and Novolin. Monday’s settlement resolves Attorney General ...

your insulin costs will be $35 a month, period," he said. The agreement reached with Novo Nordisk covers popular brands like Flasp, Novolin, NovoLog and Tresib, with three vials or two packs of ...